NM_002055.5:c.1111G>A
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_002055.5(GFAP):c.1111G>A(p.Glu371Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002055.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFAP | NM_002055.5 | c.1111G>A | p.Glu371Lys | missense_variant | Exon 6 of 9 | ENST00000588735.3 | NP_002046.1 | |
GFAP | NM_001363846.2 | c.1111G>A | p.Glu371Lys | missense_variant | Exon 6 of 10 | NP_001350775.1 | ||
GFAP | NM_001242376.3 | c.1111G>A | p.Glu371Lys | missense_variant | Exon 6 of 7 | NP_001229305.1 | ||
GFAP | NM_001131019.3 | c.1111G>A | p.Glu371Lys | missense_variant | Exon 6 of 8 | NP_001124491.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Alexander disease Pathogenic:1
The GFAP c.1111G>A (p.Glu371Lys) variant is a missense variant located within the Coil 2B region of the alpha-helical rod domain of the protein. The p.Glu371Lys variant has not been reported in the literature in association with Alexander disease. However, three different variants at the same amino acid position have been reported in two studies in individuals affected with Alexander disease (Kawai et al. 2005; Prust et al. 2011). The p.Glu371Lys variant is not found in the Genome Aggregation Database in a region of good sequence coverage, so the variant is presumed to be rare. Based on the absence from population frequency databases, the location in a mutational hotspot of a functional domain and the identification in a de novo state, the p.Glu371Lys variant is classified as pathogenic for Alexander disease. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Glu371 amino acid residue in GFAP. Other variant(s) that disrupt this residue have been observed in individuals with GFAP-related conditions (PMID: 16168595, 26478912), which suggests that this may be a clinically significant amino acid residue. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1199219). This missense change has been observed in individual(s) with Alexander disease (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 371 of the GFAP protein (p.Glu371Lys). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.